Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program

KIRKLAND, Wash., Nov. 29, 2017 -- (Healthcare Sales & Marketing Network) -- Mavupharma (Mavu) announced today that it has secured $20 million in a Series A financing led by Frazier Healthcare Partners and joined by Alpine BioVentures. Mavu is developing o... Biopharmaceuticals, Venture Capital Mavupharma, stimulator of interferon genes, STING pathway
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news